Skip to Content

IG 271 1.25mg (Ramipril 1.25 mg)

Pill with imprint IG 271 1.25mg is Yellow, Capsule-shape and has been identified as Ramipril 1.25 mg. It is supplied by InvaGen Pharmaceuticals, Inc..

Ramipril is used in the treatment of high blood pressure; diabetic kidney disease; left ventricular dysfunction; heart attack; heart failure (and more), and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Ramipril 1.25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for IG 271 1.25mg

Ramipril

Imprint:
IG 271 1.25mg
Strength:
1.25 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Angiotensin Converting Enzyme Inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
InvaGen Pharmaceuticals, Inc.
Inactive Ingredients:
pregelatinized starch
gelatin
titanium dioxide
D&C Yellow No. 10
FD&C Yellow No. 6
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide